Furthermore, a recent study conducted on 738 European patients with IBD using a candidate gene approach identified 19 functional polymorphisms in genes involved in NFκB activation via TLR pathways, TNF-α signaling, and NFκB-regulated cytokines as significant predictors of response to anti-TNF therapy. This evidence concerns the gene TNF and inflammatory bowel disease.